Melissa Theresa Rosenhan, PA-C

Melissa Rosenhan practices at Elite Physical Therapy and Rehabilitation - Purchase in Purchase, New York.

Melissa Rosenhan's NPI, 1932680402, was assigned on August 23, 2018. Melissa Rosenhan holds New York license 022517.

Melissa Rosenhan's primary practice is Elite Physical Therapy and Rehabilitation - Purchase, at 3010 Westchester Ave, Purchase, NY 10577. The practice phone is (914) 328-3888.

Melissa Rosenhan's primary practice is Elite Physical Therapy and Rehabilitation - Purchase in Purchase, New York. The medical group on file is Schweiger Dermatology Group. Dmand AI also links Melissa Rosenhan to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Melissa Rosenhan practices, 2 sites in all. Vendor and product names are available with a free account.

Physician assistant is Melissa Rosenhan's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Melissa Rosenhan is licensed in New York.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, contact dermatitis, hives, itchy rashes, joint cyst and minor injury on trunk among the conditions Melissa Rosenhan treats.

CMS data shows 82 Medicare services from Melissa Rosenhan across 3 procedure codes in 2024, for 53 Medicare patients. Medicare paid $4,949 for them. Every service was in an office.

CMS counts 53 Medicare patients who saw Melissa Rosenhan in 2024. The largest group is 65 to 74, with 33 patients. 75% of them have high cholesterol, and 66% have high blood pressure. Their average risk score is 1.03, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Melissa Rosenhan's median patient age at 36, with 64% women.

In 2024, Melissa Rosenhan wrote 125 Medicare Part D claims for 54 patients. 94% of them were for generic drugs. CMS names the drug for 72 of them, across 4 drugs with 11 or more claims each, at $1,214 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Melissa Rosenhan for performance year 2024, reported as part of a group. Melissa Rosenhan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Melissa Rosenhan as offering telehealth.

CMS Open Payments shows 65 general payments to Melissa Rosenhan from 14 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Incyte Corporation paid the most, $348.